245
Participants
Start Date
January 9, 2023
Primary Completion Date
December 9, 2024
Study Completion Date
July 9, 2025
Vamikibart
Participants will receive vamikibart IVT injection
Sham
Participants will receive a sham procedure that mimics an IVT injection.
Chang Gung Medical Foundation - Linkou, Taoyuan District
Medizinische Universität Wien, Vienna
Kepler Universitätskliniken GmbH - Med Campus III, Linz
LKH-Univ.Klinikum Graz, Graz
Taipei Veterans General Hospital, Taipei
Seoul National University Bundang Hospital, Seongnam-si
ASL 4 SSR Ospedale Santa Maria di Montallegro, Rapallo
Ajou University Medical Center, Gyeonggi-do
Irccs Ospedale San Raffaele, Milan
Asst Fatebenefratelli Sacco, Milan
Cumberland Valley Retina PC, Hagerstown
Wake Forest Baptist Health Eye Centre, Winston-Salem
Palmetto Retina Center, West Columbia
Tennessee Retina PC, Nashville
AUSL ? IRCCS Santa Maria Nuova, Reggio Emilia
Yeungnam University Medical Center, Daegu
The Ohio State University Investigational Drug Services, Columbus
University Hospitals Cleveland Medical Center, Cleveland
Pusan National University Hospital, Busan
VitreoRetinal Surgery, PLLC., Minneapolis
Instituto de Oftalmologia Monterrey - Vision100 (IOM), Monterrey
Texas Retina Associates, Dallas
Austin Clinical Research LLC, Austin
Colorado Retina Associates, PC, Lakewood
Kaiser Permanente Southern California, Los Angeles
Oregon Health & Science Uni, Portland
Peking Union Medical College Hospital, Beijing
Beijing Tongren Hospital, Beijing
The Second Hospital of Jilin University, Changchun
Shanghai First People's Hospital, Shanghai
Tianjin Medical University Eye Hospital, Tianjin
Eye Hospital, Wenzhou Medical University, Wenzhou
The First Affiliated Hospital, Chongqing Medical University, Chongqing
Ren Min Hospital Affiliated Wu Han University, Wuhan
Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou
Rambam Medical Center, Haifa
Meir Medical Center, Kfar Saba
Rabin MC, Petah Tikva
Assuta Hashalom Medical Center, Tel Aviv
Kaplan Medical Center, Rehovot
Hadassah MC, Jerusalem
Retina Vitreous Associates of Florida, St. Petersburg
Truhlsen Eye Institute, Omaha
Envision Ocular, LLC, Bloomfield
Erie Retina Research, Erie
Retina Clinic, São Paulo
Universidade Federal de Sao Paulo - UNIFESP*X, São Paulo
CEMAPE - Centro Médico, São Paulo
Fiocruz - Fundação Oswaldo Cruz, Rio de Janeiro
Kensington Vision and Research Centre, Toronto
Hôpital Maisonneuve - Rosemont, Montreal
CHU de Quebec-Universite Laval, Québec
Second Affiliated Hospital Zhejiang University College of Medicine, Hangzhou
Mackay Memorial Hospital, Taipei
Hospital de la Ceguera APEC, Mexico City
Het Oogziekenhuis Rotterdam, Rotterdam
Universitair Medisch Centrum Utrecht, Utrecht
OFTALMIKA Sp. z o.o, Bydgoszcz
Gabinet Okulistyczny Prof Edward Wylegala, Katowice
SP ZOZ Szpital Uniwersytecki w Krakowie Oddzia? Kliniczny Okulistyki i Onkologii Okulistycznej, Krakow
SPSK nr 1 w Lublinie, Lublin
SPEKTRUM Osrodek Okulistyki Klinicznej, Wroclaw
AIBILI - Association for Innovation and Biomedical Research on Light, Coimbra
Instituto de Oftalmologia Dr. Gama Pinto, Lisbon
Hospital de Santa Maria, Lisbon
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Seoul St Mary's Hospital, Seoul
Kim's Eye Hospital, Seoul
Queen Elizabeth Hospital, Birmingham
Bradford Royal Infirmary, Bradford
Sussex Eye Hospital, Brighton
Bristol Eye Hospital, Bristol
University Hospital of Wales, Cardiff
Gloucestershire Hospitals NHS Foundation Trust, Gloucestershire
Royal Liverpool University Hospital, Liverpool
Western Eye Hospital, London
Maidstone Hospital, Maidstone, Kent
James Cook Hospital, Middlesbrough
Hoffmann-La Roche
INDUSTRY